Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Stress ligands are a group of cell surface proteins that are upregulated in response to various forms of cellular stress, such as DNA damage, oncogene activation, oxidative stress, or infection. They function by signaling distress to the immune system by binding to the activating receptor NKG2D on NK cells and certain T cell subsets, enabling immune surveillance and elimination of damaged or transformed cells. Key human stress ligands include MICA, MICB, and ULBP1-6. Their expression is regulated at multiple levels and plays a dual role in disease, acting as both targets for immune recognition and potential mediators of immune evasion.
Enhance ligand induction on tumor surfaces or inhibit their shedding for improved immunotherapy outcomes
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Stress Ligands (NKG2D ligands) (NKG2DLs).